Biomarkers for antitumor activity of bevacizumab in gastric cancer models

BACKGROUND: Bevacizumab is a humanized monoclonal antibody to human vascular endothelial cell growth factor (VEGF) and has been used for many types of cancers such as colorectal cancer, non-small cell lung cancer, breast cancer, and glioblastoma. Bevacizumab might be effective against gastric cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita-Kashima, Yoriko, Fujimoto-Ouchi, Kaori, Yorozu, Keigo, Kurasawa, Mitsue, Yanagisawa, Mieko, Yasuno, Hideyuki, Mori, Kazushige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292441/
https://www.ncbi.nlm.nih.gov/pubmed/22273502
http://dx.doi.org/10.1186/1471-2407-12-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292441/
https://www.ncbi.nlm.nih.gov/pubmed/22273502
http://dx.doi.org/10.1186/1471-2407-12-37

Ejemplares similares